Related Articles
In vitro modeling of HER2-targeting therapy in disseminated prostate cancer
Aberrant expression of the PRAC gene in prostate cancer
Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [111In]-labeled CHX-A''DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines
Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone
p53 is involved in the inhibition of cell proliferation mediated by activin A in cultured human prostate cancer LNCaP cells